Results 211 to 220 of about 581,864 (396)

Shape‐Selective Molecular Separations Enabled by Rigid and Interconnected Confinements Engineered in Conjugated Microporous Polymer Membranes

open access: yesAdvanced Science, EarlyView.
Conjugated microporous polymer membranes with narrowly distributed network pores are prepared by diffusion‐modulated electropolymerization. This approach precisely controls the monomer diffusion and coupling processes, regulating the crosslinking degree to prevent broad aggregate pores and microporous defects.
Yanqiu Lu   +4 more
wiley   +1 more source

Defect Engineering in Wüstite: Unlocking Control Over Iron Morphologies in Gas‐Solid Reduction

open access: yesAdvanced Science, EarlyView.
In this paper, a direct link between the concentration of defects in wüstite (FexO) and the resultant iron microstructure is established. By integrating the muti‐point nucleation and morphological evolution of iron at defect sites, a multiscale perspective on how defect engineering in FexO modulates the morphologies of iron has been developed ...
Qinghui Wu   +5 more
wiley   +1 more source

Integrating FT-ICR MS and Machine Learning to Forecast Acid Content Across Boiling Cuts. [PDF]

open access: yesAnal Chem
Roque JV   +7 more
europepmc   +1 more source

Decursin‐Loaded Nanovesicles Target Macrophages Driven by the Pathological Process of Atherosclerosis

open access: yesAdvanced Science, EarlyView.
This study presents decursin, a traditional Chinese medicine monomer, that inhibits lipid accumulation and inflammation in atherosclerosis through PKCδ interaction. A novel targeted delivery system (ALD@EM) is developed to overcome decursin's short half‐life, combining antibody‐mediated targeting, LDL‐facilitated chemotaxis, and enhanced macrophage ...
Hui Chen   +13 more
wiley   +1 more source

A Self‐Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple‐Negative Breast Cancer Therapy

open access: yesAdvanced Science, EarlyView.
A CTGF‐LYTAC nanoplatform is developed to selectively degrade connective tissue growth factor (CTGF) in triple‐negative breast cancer (TNBC), inhibiting TGF‐β signaling and cell interactions in the tumor microenvironment (TME). This strategy effectively suppresses tumor growth and metastasis, outperforming antibody‐based therapy.
Jia‐Yi Lin   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy